Antiviral chemotherapy today and tomorrow.

Antiviral chemotherapy has come of age. Several compounds, i.e. amantadine, rimantadine, idoxuridine, trifluridine, vidarabine, acyclovir, ribavirin and azidothymidine, have been licensed for clinical use and other promising compounds may follow soon. The search for new antiviral agents has been boosted by the advent of AIDS, but the activity spectrum of the newly developed antivirals not only spans retroviruses but also various other virus infections, i.e. herpes-, adeno-, pox- and rhinovirus infections. Clinical trials have been started with a variety of these new compounds and the prospects for an effective chemotherapy of several viral diseases certainly look bright.
AuthorsE De Clercq
JournalAnnales de médecine interne (Ann Med Interne (Paris)) Vol. 139 Issue 2 Pg. 84-6 ( 1988) ISSN: 0003-410X [Print] FRANCE
PMID3293505 (Publication Type: Clinical Trial, Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Acquired Immunodeficiency Syndrome (drug therapy)
  • Antiviral Agents (pharmacokinetics, therapeutic use)
  • Biological Availability
  • Clinical Trials as Topic
  • Drug Therapy (trends)
  • Humans
  • Virus Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: